We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Nyxoah SA (NYXH) NPV

Sell:€7.58 Buy:€7.86 Change: €0.04 (0.51%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:€7.58
Buy:€7.86
Change: €0.04 (0.51%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:€7.58
Buy:€7.86
Change: €0.04 (0.51%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Contact details

Address:
Rue Edouard Belin 12
MONT-SAINT-GUIBERT
1435
Belgium
Telephone:
+32 (2) 6121755
Website:
https://www.nyxoah.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NYXH
ISIN:
BE0974358906
Market cap:
€269.39 million
Shares in issue:
34.39 million
Sector:
Health Care Equipment
Exchange:
Euronext Brussels
Country:
Belgium
Currency:
Euro
Indices:
n/a

Key personnel

  • Olivier Taelman
    Chief Executive Officer, Executive Director
  • John Landry
    Chief Financial Officer
  • Loic Moreau
    President - International
  • Maurits Boon
    Chief Medical Officer
  • Christoph Eigenmann
    Chief Commercial Officer
  • Scott Holstine
    Chief Commercial Officer
  • Francis Kim
    Chief Regulatory and Quality Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.